-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
SQZ Biotechnologies Co quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q3 2023.
- SQZ Biotechnologies Co Operating Income (Loss) for the quarter ending September 30, 2023 was -$23.8M, a 3.04% decline year-over-year.
- SQZ Biotechnologies Co Operating Income (Loss) for the twelve months ending September 30, 2023 was -$73.2M, a 6.74% increase year-over-year.
- SQZ Biotechnologies Co annual Operating Income (Loss) for 2022 was -$80.7M, a 17.3% decline from 2021.
- SQZ Biotechnologies Co annual Operating Income (Loss) for 2021 was -$68.8M, a 34.7% decline from 2020.
- SQZ Biotechnologies Co annual Operating Income (Loss) for 2020 was -$51.1M, a 49% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)